HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice.

Abstract
The ability to activate pro-matrix metalloproteinase (pro-MMP)-2 via membrane type-MMP is a hallmark of human breast cancer cell lines that show increased invasiveness, suggesting that MMP-2 contributes to human breast cancer progression. To investigate this, we have stably transfected pro-MMP-2 into the human breast cancer cell line MDA-MB-231, which lacks MMP-2 expression but does express its cell surface activator, membrane type 1-MMP. Multiple clones were derived and shown to produce pro-MMP-2 and to activate it in response to concanavalin A. In vitro analysis showed that the pro-MMP-2-transfected clones exhibited an increased invasive potential in Boyden chamber and Matrigel outgrowth assays, compared with the parental cells or those transfected with vector only. When inoculated into the mammary fat pad of nude mice, each of the MMP-2-tranfected clones grew faster than each of the vector controls tested. After intracardiac inoculation into nude mice, pro-MMP-2-transfected clones showed a significant increase in the incidence of metastasis to brain, liver, bone, and kidney compared with the vector control clones but not lung. Increased tumor burden was seen in the primary site and in lung metastases, and a trend toward increased burden was seen in bone, however, no change was seen in brain, liver, or kidney. This data supports a role for MMP-2 in breast cancer progression, both in the growth of primary tumors and in their spread to distant organs. MMP-2 may be a useful target for breast cancer therapy when refinement of MMP inhibitors provides for MMP-specific agents.
AuthorsAngus M Tester, Mark Waltham, Se-Jeong Oh, Seog-Nyeon Bae, Margaret M Bills, Emma C Walker, Francis G Kern, William G Stetler-Stevenson, Marc E Lippman, Erik W Thompson
JournalCancer research (Cancer Res) Vol. 64 Issue 2 Pg. 652-8 (Jan 15 2004) ISSN: 0008-5472 [Print] United States
PMID14744781 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Enzyme Precursors
  • Recombinant Proteins
  • Gelatinases
  • Metalloendopeptidases
  • progelatinase
Topics
  • Animals
  • Brain Neoplasms (pathology, secondary)
  • Breast Neoplasms (pathology)
  • Cell Division (genetics)
  • Cell Line, Tumor
  • Enzyme Precursors (genetics, metabolism)
  • Female
  • Gelatinases (genetics, metabolism)
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Kidney Neoplasms (pathology, secondary)
  • Liver Neoplasms (pathology, secondary)
  • Lung Neoplasms (pathology, secondary)
  • Metalloendopeptidases (genetics, metabolism)
  • Mice
  • Mice, Nude
  • Neoplasm Invasiveness
  • Neoplasm Metastasis (pathology)
  • Recombinant Proteins (metabolism)
  • Transfection
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: